Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Altravax wins $3.45M NIAID grants to develop HIV-1 vaccine
The National Institute of Allergy and Infectious Diseases awarded Altravax two grants totaling $3.45 million to support its HIV-1 vaccine research. Altravax plans to use technology from Maxygen to develop vaccines that provide protection against multiple strains of HIV-1.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .